These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 7527645)

  • 21. Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma.
    Riccardi A; Ucci G; Luoni R; Castello A; Coci A; Magrini U; Ascari E
    J Clin Pathol; 1990 Jun; 43(6):469-75. PubMed ID: 2199532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibody Ki-67 as a marker of proliferative activity in monoclonal gammopathies.
    Girino M; Riccardi A; Luoni R; Ucci G; Cuomo A
    Acta Haematol; 1991; 85(1):26-30. PubMed ID: 2011926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression.
    Kline M; Donovan K; Wellik L; Lust C; Jin W; Moon-Tasson L; Xiong Y; Witzig TE; Kumar S; Rajkumar SV; Lust JA
    Leuk Res; 2007 May; 31(5):591-8. PubMed ID: 16879867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma].
    Schleiffenbaum BE
    Praxis (Bern 1994); 2012 Nov; 101(24):1521-9; quiz 1530-1. PubMed ID: 23184544
    [No Abstract]   [Full Text] [Related]  

  • 25. Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis.
    Andersen NF; Kristensen IB; Preiss BS; Christensen JH; Abildgaard N
    Eur J Haematol; 2015 Sep; 95(3):211-7. PubMed ID: 25353275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow angiogenesis and circulating plasma cells in multiple myeloma.
    Kumar S; Witzig TE; Greipp PR; Rajkumar SV
    Br J Haematol; 2003 Jul; 122(2):272-4. PubMed ID: 12846897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma cell proliferation in monoclonal gammopathies: measurement using BU-1 antibody in flow cytometry and microscopy: comparison with serum thymidine kinase.
    Schambeck CM; Wick M; Bartl R; Lamerz R; Fateh-Moghadam A
    J Clin Pathol; 1995 May; 48(5):477-81. PubMed ID: 7629298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myeloma.
    Sezer O; Niemöller K; Jakob C; Zavrski I; Heider U; Eucker J; Kaufmann O; Possinger K
    Ann Hematol; 2001 Oct; 80(10):598-601. PubMed ID: 11732871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of the bone marrow plasma cell cytoplasmic light chain ratio in differentiating between multiple myeloma and monoclonal gammopathy of undetermined significance.
    Majumdar G; Grace RJ; Singh AK; Slater NG
    Leuk Lymphoma; 1992 Dec; 8(6):491-3. PubMed ID: 1297481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma.
    Ribatti D; Vacca A; Nico B; Quondamatteo F; Ria R; Minischetti M; Marzullo A; Herken R; Roncali L; Dammacco F
    Br J Cancer; 1999 Feb; 79(3-4):451-5. PubMed ID: 10027312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenesis in multiple myeloma.
    Rajkumar SV; Kyle RA
    Semin Oncol; 2001 Dec; 28(6):560-4. PubMed ID: 11740809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of correlation between plasma cell thymidine labelling index and serum beta-2-microglobulin in monoclonal gammopathies.
    Boccadoro M; Durie BG; Frutiger Y; Gavarotti P; Redoglia V; Massaia M; D'Alberto M; Marmont F; Gallamini A; Tribalto M
    Acta Haematol; 1987; 78(4):239-42. PubMed ID: 3122489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA aneuploidy, increased proliferation and nuclear area of plasma cells in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Leo E; Kropff M; Lindemann A; Steinfurth G; Esselborn H; Rossner R; Adler CP; Böcking A
    Anal Quant Cytol Histol; 1995 Apr; 17(2):113-20. PubMed ID: 7612131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.
    Niemöller K; Jakob C; Heider U; Zavrski I; Eucker J; Kaufmann O; Possinger K; Sezer O
    J Cancer Res Clin Oncol; 2003 Apr; 129(4):234-8. PubMed ID: 12700896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy.
    Boccadoro M; Gavarotti P; Fossati G; Pileri A; Marmont F; Neretto G; Gallamini A; Volta C; Tribalto M; Testa MG
    Br J Haematol; 1984 Dec; 58(4):689-96. PubMed ID: 6518137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness and reproducibility of cytomorphologic evaluations to differentiate myeloma from monoclonal gammopathies of unknown significance.
    Millá F; Oriol A; Aguilar J; Aventín A; Ayats R; Alonso E; Domingo A; Feliu E; Florensa L; López A; Pérez-Vila E; Rozman M; Sánchez C; Vallespí T; Woessner S
    Am J Clin Pathol; 2001 Jan; 115(1):127-35. PubMed ID: 11190798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44.
    Vacca A; Di Loreto M; Ribatti D; Di Stefano R; Gadaleta-Caldarola G; Iodice G; Caloro D; Dammacco F
    Am J Hematol; 1995 Sep; 50(1):9-14. PubMed ID: 7545353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of bone marrow fibrosis and angiogenesis in monitoring patients with multiple myeloma.
    Babarović E; Valković T; Štifter S; Budisavljević I; Seili-Bekafigo I; Duletić-Načinović A; Lučin K; Jonjić N
    Am J Clin Pathol; 2012 Jun; 137(6):870-8. PubMed ID: 22586045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow angiogenesis in multiple myeloma: effect of therapy.
    Kumar S; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Greipp PR; Rajkumar SV
    Br J Haematol; 2002 Dec; 119(3):665-71. PubMed ID: 12437642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.